|
⚲
|
| Keyboard |
| Upjohn Inc | |
|---|---|
| Ticker | VTRS |
| CIK # | 0001792044 |
| CUSIP | 92556V106 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 235 East 42Nd Street, New York, NY 10017 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001792044] | 10-K | |
| [0001792044] | 10-Q | |
| [0001792044] | 3 | |
| [0001792044] | 4 | |
| [0001792044] | 5 | |
| [0001792044] | 8-K | |
| [0001792044] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Vanguard Capital Management LLC | Viatris Inc | [2026-04-30] | 0.0 |
| State Street Corp | Viatris Inc | [2025-08-11] | 0.0 |
| Price T Rowe Associates Inc /MD/ | Viatris Inc | [2025-05-14] | 0.0 |
| Davis Selected Advisers | Viatris Inc | [2025-01-24] | 0.0 |
| Davis Selected Advisers | Viatris Inc | [2024-02-09] | 5.2 |
| State Street Corp | Viatris Inc | [2023-02-07] | 5.1 |
| Vanguard Group Inc | Viatris Inc | [2022-02-10] | 10.84 |
| Wellington Management Group LLP | Viatris Inc | [2021-02-04] | 5.74 |
| BlackRock Inc | Viatris Inc | [2021-02-02] | 7.3 |
| Vanguard Group Inc | Viatris Inc | [2021-01-08] | 10.62 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Campbell Paul
Common Stock
|
2026-03-23 | Sell | 21,350 | $13.28 | 283,528 |
|
Enrietti Andrew
Restricted Stock Units · derivative
|
2026-03-06 | Option exercise | 19,169 | $0.00 | |
|
Higgins Melina E
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 15,890 | $0.00 | |
|
Vivaldi Coelho Rogerio
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 15,890 | $0.00 | |
|
Simmons David S
Restricted Stock Units · derivative
|
2026-03-06 | Option exercise | 22,820 | $0.00 | |
|
Campbell Paul
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 56,727 | $0.00 | |
|
Campbell Paul
Common Stock
|
2026-03-06 | Option exercise | 27,603 | $0.00 | |
|
Parrish Mark W
Dividend Equivalent Units · derivative
|
2026-03-06 | Option exercise | 1,174.49 | $0.00 | |
|
Vivaldi Coelho Rogerio
Dividend Equivalent Units · derivative
|
2026-03-06 | Option exercise | 1,174.49 | $0.00 | |
|
Damelio Frank A
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 15,890 | $0.00 | |
|
Groothuis Leo Frans
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 15,890 | $0.00 | |
|
Simmons David S
Dividend Equivalent Units · derivative
|
2026-03-06 | Option exercise | 523.04 | $0.00 | |
|
Smith Scott Andrew
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 256,074 | $0.00 | |
|
Campbell Paul
Dividend Equivalent Units · derivative
|
2026-03-06 | Option exercise | 1,370.62 | $0.00 | |
|
Enrietti Andrew
Common Stock
|
2026-03-06 | Tax withheld | 415 | $14.16 | 5,876 |
|
Lyons Dillon JoEllen
Dividend Equivalent Units · derivative
|
2026-03-06 | Option exercise | 1,174.49 | $0.00 | |
|
Mark Richard A
Restricted Stock Units · derivative
|
2026-03-06 | Grant | 15,890 | $0.00 | |
|
Parrish Mark W
Restricted Stock Units · derivative
|
2026-03-06 | Option exercise | 23,660 | $0.00 | |
|
Damelio Frank A
Restricted Stock Units · derivative
|
2026-03-06 | Option exercise | 25,112 | $0.00 | |
|
Vivaldi Coelho Rogerio
Restricted Stock Units · derivative
|
2026-03-06 | Option exercise | 23,660 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 1,021 | 902,660,046 |
| 2025-12-31 | 1,008 | 889,162,134 |
| 2025-09-30 | 971 | 871,548,391 |
| 2025-06-30 | 974 | 888,673,164 |
| 2025-03-31 | 1,012 | 881,931,889 |
| 2024-12-31 | 1,039 | 922,836,010 |
| 2024-09-30 | 1,006 | 893,019,475 |
| 2024-06-30 | 1,003 | 908,471,572 |
| 2024-03-31 | 1,016 | 929,341,449 |
| 2023-12-31 | 1,024 | 921,487,899 |
| 2023-09-30 | 964 | 873,654,821 |
| 2023-06-30 | 994 | 862,038,831 |